Medtronic Completes Acquisition of Transneuronix
Jul 5, 2005
 Print this page

Medical appliance maker Medtronic, Inc. (Minneapolis, MN, U.S.) announced that it has completed its previously announced acquisition of Transneuronix, Inc., a privately held medical device company focused on therapies designed to treat obesity by electrical stimulation of the stomach.

The acquisition follows Medtronic's recent announcement regarding the formation of a new business unit, Medtronic Obesity Management. Transneuronix has been conducting research using gastric electrical stimulation for the treatment of obesity for more than 8 years in the U.S. and Europe utilizing an implantable pacemaker-like device that delivers electrical pulses to the stomach.

Back to Breaking News